Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Learn effective ways to develop your money-making abilities. Enhance your skills and grow your wealth with practical strategies.
14,330 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Bill Gates’ foundation says a sudden withdrawal from a major AI summit was a move to keep the focus squarely on the e...
Visa extends its four-year partnership with Red Bull Racing, expanding branding and fan experiences amid lingering qu...
If you think it's late Vertiv, you're not alone. Yet the data-center and AI infrastructure cycle still offers upside....
When a mining stock dropped today, investors often wonder what behind-the-scenes factors pushed the move. This guide ...
Bitcoin and Ether defy a tariff shock, keeping prices steady as markets assess broader implications for crypto liquid...
XRP remains range-bound after a volatile 2025, with traders eyeing regulatory clarity and macro trends as potential c...
Keller Williams rolls out a redesigned Command CRM with more than 75 integrations, backed by Stone Point Capital. The...
A Supreme Court ruling is reshaping expectations for U.S. tariff policy as levies near their July expiry. Morgan Stan...
Investors are eyeing Life Time's Q4 2025 earnings to gauge membership momentum, pricing discipline, and growth strate...
Looking for cash flow that lasts through retirement without chasing risky yields? Meet two resilient dividend stalwar...
Early 2026 shows Asia-led gains outpacing the U.S., with Asia-focused ETFs rising as tech and earnings momentum impro...